drugset / Trial / NCT02477267

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

NCT02477267

Phase 1 Completed 47 enrolled INSYS Therapeutics Inc
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of this study is to compare the bioavailability of a test formulation of Buprenorphine Naloxone Sublingual (SL) spray to that of a single dose of Suboxone® (buprenorphine and naloxone) sublingual film, under fasted conditions.

Timeline

Start
2015-06
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Other
Subject Buprenorphine naloxone sublingual spray Unknown Other

Indications